statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	540
SG - Singapore	107
IT - Italia	104
PL - Polonia	74
CN - Cina	58
SE - Svezia	48
VN - Vietnam	44
HK - Hong Kong	37
BR - Brasile	27
DE - Germania	23
BG - Bulgaria	22
FR - Francia	21
RU - Federazione Russa	20
KR - Corea	15
NL - Olanda	15
IE - Irlanda	12
FI - Finlandia	10
GB - Regno Unito	10
CA - Canada	7
IN - India	6
JP - Giappone	6
SN - Senegal	6
ZA - Sudafrica	5
MA - Marocco	4
UA - Ucraina	4
AR - Argentina	3
CH - Svizzera	3
EG - Egitto	3
HU - Ungheria	3
ID - Indonesia	3
UZ - Uzbekistan	3
BD - Bangladesh	2
BE - Belgio	2
BW - Botswana	2
ES - Italia	2
IQ - Iraq	2
MX - Messico	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AT - Austria	1
AU - Australia	1
BA - Bosnia-Erzegovina	1
BN - Brunei Darussalam	1
CG - Congo	1
CO - Colombia	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
ET - Etiopia	1
HR - Croazia	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
LT - Lituania	1
MU - Mauritius	1
MY - Malesia	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PK - Pakistan	1
PY - Paraguay	1
QA - Qatar	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
VE - Venezuela	1
Totale	1.287

Nome	#
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients	272
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine	255
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations	204
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring	172
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer	155
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma	143
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma	135
Totale	1.336

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	23	0	0	0	0	0	0	0	0	0	10	1	12
2021/2022	155	4	4	2	5	0	64	18	2	13	8	2	33
2022/2023	144	15	33	14	18	13	19	0	7	11	4	7	3
2023/2024	149	5	9	6	22	9	21	25	41	1	1	8	1
2024/2025	227	5	2	3	24	33	23	15	8	29	31	31	23
2025/2026	431	58	15	18	43	50	41	67	10	39	90	0	0
Totale													1.336

ArTS Archivio della ricerca di Trieste